In this work, we took a cross-platform approach to identify that FGF-2 is highly expressed in clinical NPC samples, and we developed various mouse models to study the molecular mechanisms underlying FGF-2–promoted tumor metastasis. The gene discussed is FGF2; the disease is neoplasm.